Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Paul Martin Busse, M.D., Ph.D.

Title
Institution
Department
Address
Phone
Fax

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01CA090713 (BUSSE, PAUL M) Jul 1, 2002 - Jun 30, 2005
    NIH/NCI
    A Phase II Trial for Neutron Capture Therapy in Melanoma
    Role: Principal Investigator
  2. R21CA094617 (PALMER, MATTHEW R) Sep 21, 2001 - Aug 31, 2004
    NIH/NCI
    Phase I / II Trial for Neutron Capture Therapy
    Role: Co-Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Pfister DG, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel DM, Bruce JY, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Galloway T, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco JW, Rodriguez CP, Shah JP, Weber RS, Weinstein G, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Jul; 18(7):873-898. PMID: 32634781.
    Citations:    
  2. Wu AC, Rehman N, Busse P. Tailored Management of Allergic Diseases by Age: One Size Does Not Fit All. J Allergy Clin Immunol Pract. 2020 Jun; 8(6):1881-1882. PMID: 32499035.
    Citations:    
  3. Kang KH, Lebow ES, Niemierko A, Bussière MR, Dewyer NA, Daly J, McKenna MJ, Lee DJ, Loeffler JS, Busse PM, Shih HA. Proton therapy for head and neck paragangliomas: A single institutional experience. Head Neck. 2020 Apr; 42(4):670-677. PMID: 31850601.
    Citations:    
  4. Niyazi M, Niemierko A, Paganetti H, Söhn M, Schapira E, Goldberg S, Adams J, Kim V, Oh KS, Hwang WL, Lu HM, Belka C, Busse PM, Loeffler JS, Shih HA. Volumetric and actuarial analysis of brain necrosis in proton therapy using a novel mixture cure model. Radiother Oncol. 2020 01; 142:154-161. PMID: 31563411.
    Citations:    
  5. Koenigs MB, Lefranc-Torres A, Bonilla-Velez J, Patel KB, Hayes DN, Glomski K, Busse PM, Chan AW, Clark JR, Deschler DG, Emerick KS, Hammon RJ, Wirth LJ, Lin DT, Mroz EA, Faquin WC, Rocco JW. Association of Estrogen Receptor Alpha Expression With Survival in Oropharyngeal Cancer Following Chemoradiation Therapy. J Natl Cancer Inst. 2019 09 01; 111(9):933-942. PMID: 30715409.
    Citations:    
  6. Aulino JM, Kirsch CFE, Burns J, Busse PM, Chakraborty S, Choudhri AF, Conley DB, Jones CU, Lee RK, Luttrull MD, Moritani T, Policeni B, Ryan ME, Shah LM, Sharma A, Shih RY, Subramaniam RM, Symko SC, Bykowski J. ACR Appropriateness Criteria® Neck Mass-Adenopathy. J Am Coll Radiol. 2019 May; 16(5S):S150-S160. PMID: 31054741.
    Citations:    
  7. Craig T, Busse P, Gower RG, Johnston DT, Kashkin JM, Li HH, Lumry WR, Riedl MA, Soteres D. Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency. Ann Allergy Asthma Immunol. 2018 12; 121(6):673-679. PMID: 30056152.
    Citations:    Fields:    
  8. Riedl MA, Aygören-Pürsün E, Baker J, Farkas H, Anderson J, Bernstein JA, Bouillet L, Busse P, Manning M, Magerl M, Gompels M, Huissoon AP, Longhurst H, Lumry W, Ritchie B, Shapiro R, Soteres D, Banerji A, Cancian M, Johnston DT, Craig TJ, Launay D, Li HH, Liebhaber M, Nickel T, Offenberger J, Rae W, Schrijvers R, Triggiani M, Wedner HJ, Dobo S, Cornpropst M, Clemons D, Fang L, Collis P, Sheridan WP, Maurer M. Evaluation of avoralstat, an oral kallikrein inhibitor, in a Phase 3 hereditary angioedema prophylaxis trial: The OPuS-2 study. Allergy. 2018 Sep; 73(9):1871-1880. PMID: 29688579.
    Citations: 1     Fields:    
  9. Banerji A, Li Y, Busse P, Riedl MA, Holtzman NS, Li HH, Davis-Lorton M, Bernstein JA, Frank M, Castaldo AJ, Long J, Zuraw B, Lumry W, Christiansen S. Hereditary angioedema from the patient's perspective: A follow-up patient survey. Allergy Asthma Proc. 2018 May 01; 39(3):212-223. PMID: 29669666.
    Citations:    Fields:    Translation:Humans
  10. Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD. NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018. J Natl Compr Canc Netw. 2018 05; 16(5):479-490. PMID: 29752322.
    Citations: 3     Fields:    
  11. da Silva Antunes R, Pham J, McMurtrey C, Hildebrand WH, Phillips E, Mallal S, Sidney J, Busse P, Peters B, Schulten V, Sette A. Urinary Peptides As a Novel Source of T Cell Allergen Epitopes. Front Immunol. 2018; 9:886. PMID: 29755469.
    Citations:    
  12. Busse P, Wechsler ME. Identification of remission in adult-onset asthma. Lancet Respir Med. 2018 06; 6(6):417-418. PMID: 29699818.
    Citations:    Fields:    
  13. Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol. 2018 04; 28(2):108-113. PMID: 29735186.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  14. Schulten V, Westernberg L, Birrueta G, Sidney J, Paul S, Busse P, Peters B, Sette A. Allergen and Epitope Targets of Mouse-Specific T Cell Responses in Allergy and Asthma. Front Immunol. 2018; 9:235. PMID: 29487600.
    Citations: 2     
  15. Budinger GRS, Kohanski RA, Gan W, Kobor MS, Amaral LA, Armanios M, Kelsey KT, Pardo A, Tuder R, Macian F, Chandel N, Vaughan D, Rojas M, Mora AL, Kovacs E, Duncan SR, Finkel T, Choi A, Eickelberg O, Chen D, Agusti A, Selman M, Balch WE, Busse P, Lin A, Morimoto R, Sznajder JI, Thannickal VJ. The Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop. J Gerontol A Biol Sci Med Sci. 2017 Oct 12; 72(11):1492-1500. PMID: 28498894.
    Citations: 3     Fields:    Translation:Humans
  16. Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD. NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017. J Natl Compr Canc Netw. 2017 06; 15(6):761-770. PMID: 28596256.
    Citations: 13     Fields:    Translation:Humans
  17. Busse P, Baker J, Martinez-Saguer I, Bernstein JA, Craig T, Magerl M, Riedl M, Shapiro R, Frank M, Lumry W, Rosch J, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M. Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients. J Allergy Clin Immunol Pract. 2017 Jul - Aug; 5(4):1142-1145. PMID: 28286153.
    Citations: 1     Fields:    
  18. Craig T, Shapiro R, Vegh A, Baker JW, Bernstein JA, Busse P, Magerl M, Martinez-Saguer I, Riedl MA, Lumry W, Williams-Herman D, Edelman J, Feuersenger H, Machnig T, Rojavin M. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. Allergy Rhinol (Providence). 2017 Mar 01; 8(1):13-19. PMID: 28381322.
    Citations:    
  19. Banerji A, Busse P, Shennak M, Lumry W, Davis-Lorton M, Wedner HJ, Jacobs J, Baker J, Bernstein JA, Lockey R, Li HH, Craig T, Cicardi M, Riedl M, Al-Ghazawi A, Soo C, Iarrobino R, Sexton DJ, TenHoor C, Kenniston JA, Faucette R, Still JG, Kushner H, Mensah R, Stevens C, Biedenkapp JC, Chyung Y, Adelman B. Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis. N Engl J Med. 2017 02 23; 376(8):717-728. PMID: 28225674.
    Citations: 13     Fields:    Translation:HumansCTClinical Trials
  20. Siddiqui F, Smith RV, Yom SS, Beitler JJ, Busse PM, Cooper JS, Hanna EY, Jones CU, Koyfman SA, Quon H, Ridge JA, Saba NF, Worden F, Yao M, Salama JK. ACR appropriateness criteria® nasal cavity and paranasal sinus cancers. Head Neck. 2017 03; 39(3):407-418. PMID: 28032679.
    Citations:    Fields:    Translation:Humans
  21. Gentile MS, Yip D, Liebsch NJ, Adams JA, Busse PM, Chan AW. Definitive proton beam therapy for adenoid cystic carcinoma of the nasopharynx involving the base of skull. Oral Oncol. 2017 02; 65:38-44. PMID: 28109466.
    Citations: 1     Fields:    Translation:Humans
  22. Magerl M, Frank M, Lumry W, Bernstein J, Busse P, Craig T, Martinez-Saguer I, Riedl MA, Shapiro R, Edelman J, Williams-Herman D, Wood DN, Feuersenger H, Rojavin M. Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry. Ann Allergy Asthma Immunol. 2017 01; 118(1):110-112. PMID: 27865714.
    Citations:    Fields:    Translation:HumansPHPublic Health
  23. Frank MM, Zuraw B, Banerji A, Bernstein JA, Craig T, Busse P, Christiansen S, Davis-Lorton M, Li HH, Lumry WR, Riedl M. Management of Children With Hereditary Angioedema Due to C1 Inhibitor Deficiency. Pediatrics. 2016 11; 138(5). PMID: 27940765.
    Citations: 3     Fields:    Translation:Humans
  24. Xu KY, Goodman E, Goswami R, Crane M, Crowley L, Busse P, Katz CL, Markowitz S, de la Hoz RE, Jordan HT, Skloot G, Wisnivesky JP. Determinants of asthma morbidity in World Trade Center rescue and recovery workers. Ann Allergy Asthma Immunol. 2016 11; 117(5):568-570. PMID: 27788891.
    Citations:    Fields:    Translation:HumansPHPublic Health
  25. Otani IM, Christiansen SC, Busse P, Camargo CA, Zuraw BL, Riedl MA, Banerji A. Emergency Department Management of Hereditary Angioedema Attacks: Patient Perspectives. J Allergy Clin Immunol Pract. 2017 Jan - Feb; 5(1):128-134.e4. PMID: 27665386.
    Citations: 1     Fields:    Translation:Humans
  26. Beitler JJ, Quon H, Jones CU, Salama JK, Busse PM, Cooper JS, Koyfman SA, Ridge JA, Saba NF, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas. Head Neck. 2016 09; 38(9):1299-309. PMID: 27330003.
    Citations: 1     Fields:    Translation:Humans
  27. Riedl MA, Bygum A, Lumry W, Magerl M, Bernstein JA, Busse P, Craig T, Frank MM, Edelman J, Williams-Herman D, Feuersenger H, Rojavin M. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data. J Allergy Clin Immunol Pract. 2016 Sep-Oct; 4(5):963-71. PMID: 27286778.
    Citations: 4     Fields:    Translation:Humans
  28. Saba NF, Salama JK, Beitler JJ, Busse PM, Cooper JS, Jones CU, Koyfman S, Quon H, Ridge JA, Siddiqui F, Worden F, Yao M, Yom SS. ACR Appropriateness criteria® for nasopharyngeal carcinoma. Head Neck. 2016 07; 38(7):979-86. PMID: 27131050.
    Citations: 2     Fields:    Translation:Humans
  29. Russo AL, Adams JA, Weyman EA, Busse PM, Goldberg SI, Varvares M, Deschler DD, Lin DT, Delaney TF, Chan AW. Long-Term Outcomes After Proton Beam Therapy for Sinonasal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):368-376. PMID: 27084654.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  30. Koyfman SA, Cooper JS, Beitler JJ, Busse PM, Jones CU, McDonald MW, Quon H, Ridge JA, Saba NF, Salama JK, Siddiqui F, Smith RV, Worden F, Yao M, Yom SS. ACR Appropriateness Criteria(®) Aggressive Nonmelanomatous Skin Cancer of the Head and Neck. Head Neck. 2016 Feb; 38(2):175-82. PMID: 26791005.
    Citations: 2     Fields:    Translation:Humans
  31. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M. Head and Neck Cancers, Version 1.2015. J Natl Compr Canc Netw. 2015 Jul; 13(7):847-55; quiz 856. PMID: 26150579.
    Citations: 35     Fields:    Translation:Humans
  32. Liu C, Yang N, Song Y, Wang L, Zi J, Zhang S, Dunkin D, Busse P, Weir D, Tversky J, Miller RL, Goldfarb J, Zhan J, Li XM. Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI™ suppresses TNF-a production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. Int Immunopharmacol. 2015 Aug; 27(2):224-31. PMID: 26004313.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  33. Banerji A, Busse P, Christiansen SC, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank M, Castaldo A, Long JF, Zuraw BL, Riedl M. Current state of hereditary angioedema management: a patient survey. Allergy Asthma Proc. 2015 May-Jun; 36(3):213-7. PMID: 25976438.
    Citations: 9     Fields:    Translation:Humans
  34. Lucas JT, Ladra MM, MacDonald SM, Busse PM, Friedmann AM, Ebb DH, Marcus KJ, Tarbell NJ, Yock TI. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1523-8. PMID: 25820437.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  35. Riedl MA, Lumry WR, Busse P, Levy H, Steele T, Dayno J, Li HH. Prevalence of hereditary angioedema in untested first-degree blood relatives of known subjects with hereditary angioedema. Allergy Asthma Proc. 2015 May-Jun; 36(3):206-12. PMID: 25803135.
    Citations: 4     Fields:    Translation:Humans
  36. Liu C, Weir D, Busse P, Yang N, Zhou Z, Emala C, Li XM. The Flavonoid 7,4'-Dihydroxyflavone Inhibits MUC5AC Gene Expression, Production, and Secretion via Regulation of NF-?B, STAT6, and HDAC2. Phytother Res. 2015 Jun; 29(6):925-32. PMID: 25809288.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  37. Christiansen SC, Bygum A, Banerji A, Busse P, Li H, Lumry W, Davis-Lorton M, Bernstein JA, Frank MM, Castaldo A, Long JF, Riedl M, Zuraw BL. Before and after, the impact of available on-demand treatment for HAE. Allergy Asthma Proc. 2015 Mar-Apr; 36(2):145-50. PMID: 25715243.
    Citations: 9     Fields:    Translation:Humans
  38. Busse P, Bygum A, Edelman J, Lumry W, Machnig T, Martinez-Saguer I, Rojavin M. Safety of C1-esterase inhibitor in acute and prophylactic therapy of hereditary angioedema: findings from the ongoing international Berinert patient registry. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):213-9. PMID: 25609333.
    Citations: 5     Fields:    Translation:Humans
  39. Li HH, Busse P, Lumry WR, Frazer-Abel A, Levy H, Steele T, Dayno J, Riedl M. Comparison of chromogenic and ELISA functional C1 inhibitor tests in diagnosing hereditary angioedema. J Allergy Clin Immunol Pract. 2015 Mar-Apr; 3(2):200-5. PMID: 25609336.
    Citations: 3     Fields:    Translation:Humans
  40. Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Schuller DE, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M. Head and neck cancers, Version 2.2014. Clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2014 Oct; 12(10):1454-87. PMID: 25313184.
    Citations: 41     Fields:    Translation:Humans
  41. Steingisser L, Acker B, Berman S, Brenner MJ, Bornstein BA, Busse P, FitzGerald TJ, Jacobson JO, Jekowsky E, Kachnic LA, Mamon H, McKee A, Shulman LN, Stevenson MA, Wazer D, Fallon JA. Bending the cost curve: a unique collaboration between radiation oncologists and Blue Cross Blue Shield of Massachusetts to optimize the use of advanced technology. J Oncol Pract. 2014 Sep; 10(5):e321-7. PMID: 25232190.
    Citations: 3     Fields:    Translation:Humans
  42. Efstathiou JA, Bvochora-Nsingo M, Gierga DP, Alphonse Kayembe MK, Mmalane M, Russell AH, Paly JJ, Brown C, Musimar Z, Abramson JS, Bruce KA, Karumekayi T, Clayman R, Hodgeman R, Kasese J, Makufa R, Bigger E, Suneja G, Busse PM, Randall TC, Chabner BA, Dryden-Peterson S. Addressing the growing cancer burden in the wake of the AIDS epidemic in Botswana: The BOTSOGO collaborative partnership. Int J Radiat Oncol Biol Phys. 2014 Jul 01; 89(3):468-75. PMID: 24929156.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  43. Zaghi S, Ghasri P, Busse P, Clark J, Emerick K. Extensive basal cell carcinoma of the face: an extreme case of denial. Ear Nose Throat J. 2014 Jun; 93(6):E40-4. PMID: 24932829.
    Citations:    Fields:    Translation:Humans
  44. Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA, Collins SP, Craig TJ, Lumry WR, Nowak R, Pines JM, Raja AS, Riedl M, Ward MJ, Zuraw BL, Diercks D, Hiestand B, Campbell RL, Schneider S, Sinert R. A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med. 2014 Apr; 21(4):469-84. PMID: 24730413.
    Citations: 21     Fields:    Translation:Humans
  45. McBride SM, Busse PM, Clark JR, Wirth LJ, Ancukiewicz M, Chan AW. Long-term survival after distant metastasis in patients with oropharyngeal cancer. Oral Oncol. 2014 Mar; 50(3):208-12. PMID: 24387975.
    Citations: 7     Fields:    Translation:Humans
  46. Gray ST, Lin A, Curry WT, Barker FG, Busse P, Sanan A, Deschler DG, Lin DT. Delayed complications after anterior craniofacial resection of malignant skull base tumors. J Neurol Surg B Skull Base. 2014 Apr; 75(2):110-6. PMID: 24719797.
    Citations: 3     
  47. Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC, Davis-Lorton M, Frank MM, Li HH, Lumry WR, Riedl M. US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract. 2013 Sep-Oct; 1(5):458-67. PMID: 24565617.
    Citations: 26     Fields:    Translation:Humans
  48. Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian NR, Hughes M. Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013 Aug; 11(8):917-23. PMID: 23946171.
    Citations: 36     Fields:    Translation:Humans
  49. McBride SM, Parambi RJ, Jang JW, Goldsmith T, Busse PM, Chan AW. Intensity-modulated versus conventional radiation therapy for oropharyngeal carcinoma: long-term dysphagia and tumor control outcomes. Head Neck. 2014 Apr; 36(4):492-8. PMID: 23729221.
    Citations: 11     Fields:    Translation:Humans
  50. Gower RG, Lumry WR, Davis-Lorton MA, Johnston DT, Busse PJ. Current options for prophylactic treatment of hereditary angioedema in the United States: patient-based considerations. Allergy Asthma Proc. 2012 May-Jun; 33(3):235-40. PMID: 22584192.
    Citations: 4     Fields:    Translation:Humans
  51. Riedl MA, Hurewitz DS, Levy R, Busse PJ, Fitts D, Kalfus I. Nanofiltered C1 esterase inhibitor (human) for the treatment of acute attacks of hereditary angioedema: an open-label trial. Ann Allergy Asthma Immunol. 2012 Jan; 108(1):49-53. PMID: 22192966.
    Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
  52. Busse PJ. Angioedema: differential diagnosis and treatment. Allergy Asthma Proc. 2011 Sep-Oct; 32 Suppl 1:3-11. PMID: 22195755.
    Citations: 1     Fields:    Translation:Humans
  53. Gower RG, Busse PJ, Aygören-Pürsün E, Barakat AJ, Caballero T, Davis-Lorton M, Farkas H, Hurewitz DS, Jacobs JS, Johnston DT, Lumry W, Maurer M. Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies. World Allergy Organ J. 2011 Feb; 4(2 Suppl):S9-S21. PMID: 23283143.
    Citations: 8     
  54. Song Y, Qu C, Srivastava K, Yang N, Busse P, Zhao W, Li XM. Food allergy herbal formula 2 protection against peanut anaphylactic reaction is via inhibition of mast cells and basophils. J Allergy Clin Immunol. 2010 Dec; 126(6):1208-17.e3. PMID: 21134573.
    Citations: 21     Fields:    Translation:HumansAnimalsCells
  55. Zuraw BL, Busse PJ, White M, Jacobs J, Lumry W, Baker J, Craig T, Grant JA, Hurewitz D, Bielory L, Cartwright WE, Koleilat M, Ryan W, Schaefer O, Manning M, Patel P, Bernstein JA, Friedman RA, Wilkinson R, Tanner D, Kohler G, Gunther G, Levy R, McClellan J, Redhead J, Guss D, Heyman E, Blumenstein BA, Kalfus I, Frank MM. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med. 2010 Aug 05; 363(6):513-22. PMID: 20818886.
    Citations: 67     Fields:    Translation:HumansCells
  56. Zhang T, Srivastava K, Wen MC, Yang N, Cao J, Busse P, Birmingham N, Goldfarb J, Li XM. Pharmacology and immunological actions of a herbal medicine ASHMI on allergic asthma. Phytother Res. 2010 Jul; 24(7):1047-55. PMID: 19998324.
    Citations: 18     Fields:    Translation:HumansAnimalsCells
  57. Nichols AC, Finkelstein DM, Faquin WC, Westra WH, Mroz EA, Kneuertz P, Begum S, Michaud WA, Busse PM, Clark JR, Rocco JW. Bcl2 and human papilloma virus 16 as predictors of outcome following concurrent chemoradiation for advanced oropharyngeal cancer. Clin Cancer Res. 2010 Apr 01; 16(7):2138-46. PMID: 20233885.
    Citations: 16     Fields:    Translation:HumansCells
  58. Wirth LJ, Allen AM, Posner MR, Haddad RI, Li Y, Clark JR, Busse PM, Chan AW, Goguen LA, Norris CM, Annino DJ, Tishler RB. Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck. Ann Oncol. 2010 Feb; 21(2):342-347. PMID: 19892746.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  59. Kelly-Pieper K, Patil SP, Busse P, Yang N, Sampson H, Li XM, Wisnivesky JP, Kattan M. Safety and tolerability of an antiasthma herbal Formula (ASHMI) in adult subjects with asthma: a randomized, double-blinded, placebo-controlled, dose-escalation phase I study. J Altern Complement Med. 2009 Jul; 15(7):735-43. PMID: 19586409.
    Citations: 26     Fields:    Translation:HumansAnimalsCTClinical Trials
  60. Salama JK, Haddad RI, Kies MS, Busse PM, Dong L, Brizel DM, Eisbruch A, Tishler RB, Trotti AM, Garden AS. Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2009 Nov 01; 75(3):725-33. PMID: 19362781.
    Citations: 10     Fields:    Translation:Humans
  61. Michaud WA, Nichols AC, Mroz EA, Faquin WC, Clark JR, Begum S, Westra WH, Wada H, Busse PM, Ellisen LW, Rocco JW. Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. Clin Cancer Res. 2009 Mar 01; 15(5):1645-54. PMID: 19240170.
    Citations: 28     Fields:    Translation:HumansCells
  62. Lawenda BD, Arnold MG, Tokarz VA, Silverstein JR, Busse PM, McIntyre JF, Deschler DG, Baldini EH, Kachnic LA. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review. Ear Nose Throat J. 2008 Nov; 87(11):634-43. PMID: 19006065.
    Citations: 6     Fields:    Translation:Humans
  63. Kiger JL, Kiger WS, Riley KJ, Binns PJ, Patel H, Hopewell JW, Harling OK, Busse PM, Coderre JA. Functional and histological changes in rat lung after boron neutron capture therapy. Radiat Res. 2008 Jul; 170(1):60-9. PMID: 18582158.
    Citations: 1     Fields:    Translation:Animals
  64. Busse PM, Clark JR, Muse VV, Liu V. Case records of the Massachusetts General Hospital. Case 19-2008. A 63-year-old HIV-positive man with cutaneous Merkel-cell carcinoma. N Engl J Med. 2008 Jun 19; 358(25):2717-23. PMID: 18565865.
    Citations: 6     Fields:    Translation:Humans
  65. Tishler RB, Posner MR, Norris CM, Mahadevan A, Sullivan C, Goguen L, Wirth LJ, Costello R, Case M, Stowell S, Sammartino D, Busse PM, Haddad RI. Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck. Int J Radiat Oncol Biol Phys. 2006 Jul 15; 65(4):1036-44. PMID: 16682134.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  66. Haddad RI, Posner MR, Busse PM, Norris CM, Goguen LA, Wirth LJ, Blinder R, Krane JF, Tishler RB. Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach. Am J Clin Oncol. 2006 Apr; 29(2):153-7. PMID: 16601434.
    Citations: 15     Fields:    Translation:Humans
  67. Emerick KS, Mehta A, Pilch BZ, Deschler DG, Busse PM, Rocco JW. Pathology quiz case 1. Adenocarcinoma with features of mucinous adenocarcinoma (MAC) and cystadenocarcinoma (CAC). Arch Otolaryngol Head Neck Surg. 2005 Dec; 131(12):1120, 1122-3. PMID: 16365230.
    Citations:    Fields:    Translation:Humans
  68. Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R. Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer. Am J Clin Oncol. 2005 Aug; 28(4):371-8. PMID: 16062079.
    Citations: 10     Fields:    Translation:HumansCTClinical Trials
  69. Busse PJ, Wang JJ, Halm EA. Allergen sensitization evaluation and allergen avoidance education in an inner-city adult cohort with persistent asthma. J Allergy Clin Immunol. 2005 Jul; 116(1):146-52. PMID: 15990788.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  70. Karakoyun-Celik O, Norris CM, Tishler R, Mahadevan A, Clark JR, Goldberg S, Devlin P, Busse PM. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head Neck. 2005 May; 27(5):353-61. PMID: 15726587.
    Citations: 1     Fields:    Translation:Humans
  71. Kiger WS, Lu XQ, Harling OK, Riley KJ, Binns PJ, Kaplan J, Patel H, Zamenhof RG, Shibata Y, Kaplan ID, Busse PM, Palmer MR. Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam. Appl Radiat Isot. 2004 Nov; 61(5):1075-81. PMID: 15308195.
    Citations: 2     Fields:    Translation:HumansCTClinical Trials
  72. Devlin PM, Kazakin J, Adak S, Li Y, Norris CM, Tishler RB, Clark JR, Busse PM, Posner MR. Prospective phase II trial of PFL-induction chemotherapy followed by definitive local treatment for advanced squamous cell carcinoma of the head and neck: 10-year follow-up. Am J Clin Oncol. 2004 Aug; 27(4):369-75. PMID: 15289730.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  73. Chan AW, Liebsch LJ, Deschler DG, Adams JA, Vrishali LV, McIntyre JF, Pommier P, Fabian RL, Busse PM. Proton radiotherapy for T4 nasopharyngeal carcinoma. J Clin Oncol. 2004 Jul 15; 22(14_suppl):5574. PMID: 28014017.
    Citations:    
  74. Guadagnolo BA, Tishler RB, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Haddad RI. Organ preservation for patients treated with induction chemotherapy (IC) followed by radiation therapy (RT) or chemoradiation (CRT) for advanced stage squamous cell carcinoma of the larynx (SCCL). J Clin Oncol. 2004 Jul 15; 22(14_suppl):5600. PMID: 28015295.
    Citations:    
  75. Busse PM, Harling OK, Palmer MR, Kiger WS, Kaplan J, Kaplan I, Chuang CF, Goorley JT, Riley KJ, Newton TH, Santa Cruz GA, Lu XQ, Zamenhof RG. A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease. J Neurooncol. 2003 Mar-Apr; 62(1-2):111-21. PMID: 12749707.
    Citations: 19     Fields:    Translation:HumansCTClinical Trials
  76. Kiger WS, Palmer MR, Riley KJ, Zamenhof RG, Busse PM. Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy: 10B concentration predictions and dosimetric consequences. J Neurooncol. 2003 Mar-Apr; 62(1-2):171-86. PMID: 12749712.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  77. Kabalka GW, Nichols TL, Smith GT, Miller LF, Khan MK, Busse PM. The use of positron emission tomography to develop boron neutron capture therapy treatment plans for metastatic malignant melanoma. J Neurooncol. 2003 Mar-Apr; 62(1-2):187-95. PMID: 12749713.
    Citations: 8     Fields:    Translation:Humans
  78. Haddad R, Colevas AD, Tishler R, Busse P, Goguen L, Sullivan C, Norris CM, Lake-Willcutt B, Case MA, Costello R, Posner M. Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience. Cancer. 2003 Jan 15; 97(2):412-8. PMID: 12518365.
    Citations: 7     Fields:    Translation:Humans
  79. Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR. Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. Oncologist. 2003; 8(1):35-44. PMID: 12604730.
    Citations: 6     Fields:    Translation:Humans
  80. Busse PJ, Nowak-Wegrzyn AH, Noone SA, Sampson HA, Sicherer SH. Recurrent peanut allergy. N Engl J Med. 2002 Nov 07; 347(19):1535-6. PMID: 12421906.
    Citations: 7     Fields:    Translation:Humans
  81. Tishler RB, Norris CM, Colevas AD, Lamb CC, Karp D, Busse PM, Nixon A, Frankenthaler R, Lake-Willcutt B, Costello R, Case M, Posner MR. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck. Cancer. 2002 Oct 01; 95(7):1472-81. PMID: 12237916.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  82. Sonis ST, Scherer J, Phelan S, Lucey CA, Barron JE, O'Donnell KE, Brennan RJ, Pan H, Busse P, Haley JD. The gene expression sequence of radiated mucosa in an animal mucositis model. Cell Prolif. 2002 Aug; 35 Suppl 1:93-102. PMID: 12139712.
    Citations: 12     Fields:    Translation:AnimalsPHPublic Health
  83. Palmer MR, Goorley JT, Kiger WS, Busse PM, Riley KJ, Harling OK, Zamenhof RG. Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy. Int J Radiat Oncol Biol Phys. 2002 Aug 01; 53(5):1361-79. PMID: 12128139.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  84. Colevas AD, Read R, Thornhill J, Adak S, Tishler R, Busse P, Li Y, Posner M. Hypothyroidism incidence after multimodality treatment for stage III and IV squamous cell carcinomas of the head and neck. Int J Radiat Oncol Biol Phys. 2001 Nov 01; 51(3):599-604. PMID: 11597798.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  85. Kiger WS, Palmer MR, Riley KJ, Zamenhof RG, Busse PM. A pharmacokinetic model for the concentration of 10B in blood after boronophenylalanine-fructose administration in humans. Radiat Res. 2001 Apr; 155(4):611-8. PMID: 11260663.
    Citations: 3     Fields:    Translation:HumansCTClinical Trials
  86. Zuo CS, Prasad PV, Busse P, Tang L, Zamenhof RG. Proton nuclear magnetic resonance measurement of p-boronophenylalanine (BPA): a therapeutic agent for boron neutron capture therapy. Med Phys. 1999 Jul; 26(7):1230-6. PMID: 10435522.
    Citations: 3     Fields:    Translation:HumansCells
  87. Tishler RB, Busse PM, Norris CM, Rossi R, Poulin M, Thornhill L, Costello R, Peters ES, Colevas AD, Posner MR. An initial experience using concurrent paclitaxel and radiation in the treatment of head and neck malignancies. Int J Radiat Oncol Biol Phys. 1999 Mar 15; 43(5):1001-8. PMID: 10192347.
    Citations: 6     Fields:    Translation:Humans
  88. Shibata D, Hyland W, Busse P, Kim HK, Sentovich SM, Steele G, Bleday R. Immediate reconstruction of the perineal wound with gracilis muscle flaps following abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma of the rectum. Ann Surg Oncol. 1999 Jan-Feb; 6(1):33-7. PMID: 10030413.
    Citations: 31     Fields:    Translation:Humans
  89. Busse PM, Ng A, Recht A. Induction therapy for rectal carcinoma. Semin Surg Oncol. 1998 Sep; 15(2):120-5. PMID: 9730418.
    Citations: 1     Fields:    Translation:Humans
  90. Colevas AD, Busse PM, Norris CM, Fried M, Tishler RB, Poulin M, Fabian RL, Fitzgerald TJ, Dreyfuss A, Peters ES, Adak S, Costello R, Barton JJ, Posner MR. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial. J Clin Oncol. 1998 Apr; 16(4):1331-9. PMID: 9552034.
    Citations: 9     Fields:    Translation:HumansCTClinical Trials
  91. Posner MR, Johnston PG, Tishler RB, Andersen J, Fiorentino M, Busse PM, Cavacini LA, Colevas AD, Clark J, Norris CM. The Prognostic Value of Thymidylate Synthase and p53 Expression in Patients Treated with Induction Chemotherapy for Squamous Cell Carcinoma of the Head and Neck. Oncologist. 1998; 3(6):424-431. PMID: 10388134.
    Citations:    Fields:    
  92. Wong JS, Recht A, Beard CJ, Busse PM, Cady B, Chaffey JT, Come S, Fam S, Kaelin C, Lingos TI, Nixon AJ, Shulman LN, Troyan S, Silver B, Harris JR. Treatment outcome after tangential radiation therapy without axillary dissection in patients with early-stage breast cancer and clinically negative axillary nodes. Int J Radiat Oncol Biol Phys. 1997 Nov 01; 39(4):915-20. PMID: 9369141.
    Citations: 9     Fields:    Translation:Humans
  93. Clark JR, Busse PM, Norris CM, Andersen JW, Dreyfuss AI, Rossi RM, Poulin MD, Colevas AD, Tishler RB, Costello R, Lucarini JW, Lucarini D, Thornhill L, Lackey M, Peters E, Posner MR. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous cell carcinoma of the head and neck: long-term results. J Clin Oncol. 1997 Sep; 15(9):3100-10. PMID: 9294473.
    Citations: 2     Fields:    Translation:Humans
  94. Kim HK, Jessup JM, Beard CJ, Bornstein B, Cady B, Stone MD, Bleday R, Bothe A, Steele G, Busse PM. Locally advanced rectal carcinoma: pelvic control and morbidity following preoperative radiation therapy, resection, and intraoperative radiation therapy. Int J Radiat Oncol Biol Phys. 1997 Jul 01; 38(4):777-83. PMID: 9240646.
    Citations: 16     Fields:    Translation:Humans
  95. Ng AK, Recht A, Busse PM. Sphincter preservation therapy for distal rectal carcinoma: a review. Cancer. 1997 Feb 15; 79(4):671-83. PMID: 9024704.
    Citations: 5     Fields:    Translation:Humans
  96. Dreyfuss AI, Clark JR, Norris CM, Rossi RM, Lucarini JW, Busse PM, Poulin MD, Thornhill L, Costello R, Posner MR. Docetaxel: an active drug for squamous cell carcinoma of the head and neck. J Clin Oncol. 1996 May; 14(5):1672-8. PMID: 8622087.
    Citations: 34     Fields:    Translation:HumansCTClinical Trials
  97. Buswell L, Recht A, Clark J, Ravikumar T, Busse PM, Coleman CN. Combined-modality therapy of esophageal cancer with radiotherapy, etanidazole, and cisplatin-fluorouracil, with or without surgery: neurotoxicity, other toxicities and outcome. Int J Radiat Oncol Biol Phys. 1994 Jun 15; 29(3):535-40. PMID: 8005812.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  98. Busse PM, Clark JR, Beard CJ, Dreyfuss AI, Lucarini JW, Rossi R, Casey D, Norris CM. Primary site management following induction chemotherapy with cis-platinum, 5-fluorouracil, and leucovorin. Head Neck. 1993 Sep-Oct; 15(5):413-8. PMID: 8407313.
    Citations:    Fields:    Translation:HumansCTClinical Trials
  99. Jessup JM, Steele G, Mayer RJ, Posner M, Busse P, Cady B, Stone M, Jenkins R, Osteen R. Neoadjuvant therapy for unresectable pancreatic adenocarcinoma. Arch Surg. 1993 May; 128(5):559-64. PMID: 8098206.
    Citations: 34     Fields:    Translation:Humans
  100. Posner MR, Bleday R, Huberman M, Jessup JM, Busse P, Steele G. Impact of combined modality therapy on the treatment of adenocarcinoma of the colon. Semin Surg Oncol. 1993 Jan-Feb; 9(1):33-8. PMID: 8356383.
    Citations: 1     Fields:    Translation:Humans
  101. Norris CM, Busse PM, Clark JR. Evolving role of surgery after induction chemotherapy and primary site radiation in head and neck cancer. Semin Surg Oncol. 1993 Jan-Feb; 9(1):3-13. PMID: 8356382.
    Citations: 1     Fields:    Translation:Humans
  102. Jessup JM, Bleday R, Busse P, Steele G. Conservative management of rectal carcinoma: the efficacy of a multimodality approach. Semin Surg Oncol. 1993 Jan-Feb; 9(1):39-45. PMID: 8356384.
    Citations: 1     Fields:    Translation:Humans
  103. Busse PM, Jessup JM, Cady B, Bothe A, McDermott WV, Stone MD, Steele G. Effect of combined modality therapy on the surgical management of locally advanced rectal carcinoma. Semin Surg Oncol. 1993 Jan-Feb; 9(1):46-50. PMID: 8356385.
    Citations:    Fields:    Translation:Humans
  104. Steele G, Busse P, Huberman MS, LeClair JM, Falchuk ZM, Mayer RJ, Bothe A, Ravikumar TS, Stone M, Jessup JM. A pilot study of sphincter-sparing management of adenocarcinoma of the rectum. Arch Surg. 1991 Jun; 126(6):696-701; discussion 701-2. PMID: 2039356.
    Citations: 7     Fields:    Translation:Humans
  105. Busse PM, Cady B, Bothe A, Jenkins R, McDermott WV, Steele G, Stone MD. Intraoperative radiation therapy for carcinoma of the gallbladder. World J Surg. 1991 May-Jun; 15(3):352-6. PMID: 1853614.
    Citations: 2     Fields:    Translation:Humans
  106. Dreyfuss AI, Clark JR, Wright JE, Norris CM, Busse PM, Lucarini JW, Fallon BG, Casey D, Andersen JW, Klein R, et al. Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck. Ann Intern Med. 1990 Feb 01; 112(3):167-72. PMID: 2297193.
    Citations: 10     Fields:    Translation:Humans
  107. Busse PM, Stone MD, Sheldon TA, Chaffey JT, Cady B, McDermott WV, Bothe A, Jenkins R, Steele G. Intraoperative radiation therapy for biliary tract carcinoma: results of a 5-year experience. Surgery. 1989 Jun; 105(6):724-33. PMID: 2727900.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  108. Lindfors KK, Meyer JE, Busse PM, Kopans DB, Munzenrider JE, Sawicka JM. CT evaluation of local and regional breast cancer recurrence. AJR Am J Roentgenol. 1985 Oct; 145(4):833-7. PMID: 3876008.
    Citations: 1     Fields:    Translation:Humans
  109. Tolmach LJ, Busse PM. The action of caffeine on X-irradiated HeLa cells. IV. Progression delays and enhanced cell killing at high caffeine concentrations. Radiat Res. 1980 May; 82(2):374-92. PMID: 7375638.
    Citations: 5     Fields:    Translation:HumansCells
  110. Busse PM, Bose SK, Jones RW, Tolmach LJ. The action of caffeine on X-irradiated HeLa cells. III. Enhancement of X-ray-induced killing during G2 arrest. Radiat Res. 1978 Nov; 76(2):292-307. PMID: 156382.
    Citations: 22     Fields:    Translation:HumansCells
  111. Busse PM, Bose SK, Jones RW, Tolmach LJ. The action of caffeine on X-irradiated HeLa cells. II. Synergistic lethality. Radiat Res. 1977 Sep; 71(3):666-77. PMID: 911393.
    Citations: 15     Fields:    Translation:HumansCells
  112. Tolmach LJ, Jones RW, Busse PM. The action of caffeine on X-irradiated HeLa cells. I. Delayed inhibition of DNA synthesis. Radiat Res. 1977 Sep; 71(3):653-65. PMID: 897091.
    Citations: 22     Fields:    Translation:Cells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Busse's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (424)
Explore
_
Co-Authors (74)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.